Your trusted source for investing success

Tag: full year

Tech Forecast and Promising Tech Stocks To Buy in 2017

Learn about breakthrough technology about to impact lives around the globe. We cover the entire industry in our FREE investor’s report. Gain Access

VersaPay Announces Q4 and Full Year 2017 Financial Results

VersaPay Corporation (TSXV:VPY), a leading provider of cloud-based invoicing, accounts receivable management and payment solutions announced fourth quarter financial results for fourth quarter and 2017 full year results.

The company saw their Q4 Revenue grow over 126 per cent to $1.16 million in Q4 2016 while their 12 month revenue grew

Bradmer Announces Fourth Quarter and Full Year 2017 Financial Results

Bradmer Pharmaceuticals (TSXV:BMR.H) announced its fourth quarter and full year 2017 financial results.

As quoted in the press release:

For the three months ended December 31, 2017, the Company recorded a net loss of $74,000 or $0.004 per common share based on the weighted average outstanding shares of 19,659,726 during the three-month

Bio-Path Holdings Reports Full Year 2017 Financial Results

Bio-Path (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the full year ended December 31, 2017 and provided an update on recent corporate developments.

As quoted in the press release:
“During 2017 we

KemPharm Reports Fourth Quarter and Year End 2017 Results

KemPharm (NASDAQ:KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today reported its corporate and financial results for the fourth quarter and full year ended December 31, 2017, including an update on development and regulatory events involving its prodrug development pipeline.

As quoted in the press

resTORbio Reports Fourth Quarter and Full Year 2017 Financial Results

resTORbio (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel therapeutics for the treatment of aging-related diseases, today reported financial results and provided a corporate update for the fourth quarter and full year ended December 31, 2017.

As quoted in the

Are You Aware of the FDA's Plans for 2018?

Find out what's going on in our new report
 
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
AnalytixInsight Reports Fourth Quarter and Full Year 2017 Financial Results

URL: https://investingnews.com/daily/tech-investing/data-investing/analytixinsight-reports-fourth-quarter-full-year-2017-financial-results/